233 results on '"Fulcher, Gregory"'
Search Results
2. Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries
3. Initiating or switching to insulin degludec/insulin aspart in a real‐world population of adults with type 2 diabetes in Australia: results from a prospective, non‐interventional study.
4. ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in real-world settings: rationale and design
5. Correction to: Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries
6. Improving women’s experiences with gestational diabetes from culturally and linguistically diverse backgrounds in Australia: a qualitative study
7. Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes
8. A codesigned integrated kidney and diabetes model of care improves patient activation among patients from culturally and linguistically diverse backgrounds
9. Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes – A systematic review
10. Correction: ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in realworld settings: rationale and design
11. Improving women's experiences with gestational diabetes from culturally and linguistically diverse backgrounds in Australia: a qualitative study.
12. The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial
13. The regulation of carbohydrate metabolism by fatty-acid oxidation : a study of the effects of inhibiting lipolysis in patients with non-insulin-dependent diabetes mellitus
14. Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease
15. Correction to: Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries
16. Improving the experience of women with gestational diabetes from culturally and linguistically diverse backgrounds: a mixed method study
17. Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
18. A Novel Risk Classification Paradigm for Patients With Impaired Glucose Tolerance and High Cardiovascular Risk
19. Correction: ARISE—a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in realworld settings: rationale and design
20. Epidermal Protein C Levels Correspond to Local Injury Severity and Increased Clinical Support in Burn Patients
21. Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease.
22. Treatment of chronic diabetic lower leg ulcers with activated protein C: a randomised placebo-controlled, double-blind pilot clinical trial
23. co-designed integrated kidney and diabetes model of care improves mortality, glycaemic control and self-care.
24. A co-designed integrated kidney and diabetes model of care improves mortality, glycaemic control and self-care
25. Comparison of Insulin Degludec/Insulin Aspart and Biphasic Insulin Aspart 30 in Uncontrolled, Insulin-Treated Type 2 Diabetes: A Phase 3a, Randomized, Treat-to-Target Trial
26. Early protein C activation is reflective of burn injury severity and plays a critical role in inflammatory burden and patient outcomes
27. Challenges of diabetes management during the COVID-19 pandemic
28. Practical use of insulin degludec/insulin aspart in a multinational setting: beyond the guidelines
29. Guidelines for the management of gestational diabetes in pregnancy
30. Practical use of insulin degludec/insulin aspart in a multinational setting: beyond the guidelines
31. Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study
32. Different eGFR Decline Thresholds and Renal Effects of Canagliflozin: Data from the CANVAS Program
33. Challenges of diabetes management during the COVID ‐19 pandemic
34. P1028EFFECTS OF CANAGLIFLOZIN ON MAJOR ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIFFERENT BASELINE LEVELS OF TYPE 2 DIABETES MELLITUS DISEASE SEVERITY: RESULTS FROM THE CANVAS PROGRAM
35. HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment
36. Routine glucose assessment in the emergency department for detecting unrecognised diabetes: a cluster randomised trial
37. Plasma protein C levels are directly associated with better outcomes in patients with severe burns
38. Epidermal Protein C Levels Correspond to Local Injury Severity and Increased Clinical Support in Burn Patients.
39. The Relationship Among Homocysteine, Creatinine Clearance, and Albuminuria in Patients With Type 2 Diabetes
40. Additional file 4: of Patient reported barriers are associated with low physical and mental well-being in patients with co-morbid diabetes and chronic kidney disease
41. Amount and Type of Dietary Fat, Postprandial Glycemia, and Insulin Requirements in Type 1 Diabetes: A Randomized Within-Subject Trial
42. The impact of an integrated diabetes and kidney service on patients, primary and specialist health professionals in Australia: A qualitative study
43. Patient-reported barriers and outcomes associated with poor glycaemic and blood pressure control in co-morbid diabetes and chronic kidney disease
44. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial
45. Patient reported barriers are associated with low physical and mental well-being in patients with co-morbid diabetes and chronic kidney disease
46. Suboptimal behaviour and knowledge regarding overnight glycaemia in adults with type 1 diabetes is common
47. Amount and Type of Dietary Fat, Postprandial Glycemia, and Insulin Requirements in Type 1 Diabetes: A Randomized Within-Subject Trial.
48. Utility of the Hospital Admission Risk Programme diabetes risk calculator in identifying patients with type 2 diabetes at risk of unplanned hospital presentations
49. Suboptimal behaviour and knowledge regarding overnight glycaemia in adults with type 1 diabetes is common
50. Large-for-Gestational-Age Neonates in Type 1 Diabetes and Pregnancy: Contribution of Factors Beyond Hyperglycemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.